Clinical Trial Update: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating subject-reported target-lesion numeric rating scale in plaque psoriasis treated with Clobex spray 0.05%.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• CLOBEX (clobetasol propionate)

Snippet

Sponsor: Galderma R&D | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2014-07-11